Medical Science Liaison
Sobi
Medical Science Liaison
Sobi
Develops therapies for rare diseases
Make scientific exchange matter
At Sobi, we work to improve the lives of people living with rare diseases. As our Medical Science Liaison (MSL) in haemophilia, you’ll build trusted scientific relationships and bring valuable insights to our medical work in Switzerland and across the region.
Working with colleagues across Medical Affairs and other functions, you’ll support high-quality scientific exchange, medical education and stakeholder engagement. You’ll also help ensure that local perspectives inform regional and global plans.
What you’ll do
Keep your therapeutic-area knowledge current, including developments in haemophilia, treatment guidelines, products and the wider scientific landscape
About you
You bring scientific credibility, sound judgement and a collaborative approach to your work. You’re comfortable building professional relationships, communicating complex information clearly and working independently while contributing to shared goals.
You’ll also bring:
Experience in haemophilia, haematology, rare diseases or orphan drugs is an advantage. Experience in Medical Affairs, medical or clinical science, clinical development, market access, health economics, an international life sciences organisation, or new-product planning and launch activities would also be valuable.
How you work
You take initiative and responsibility, and you follow through on commitments. You’re structured, proactive and results-focused, while remaining considerate and adaptable in how you work with others.
You share knowledge, build useful networks and communicate with clarity and conviction. You bring empathy, integrity and professionalism to your interactions, and you can work with minimal supervision while staying closely connected to colleagues and stakeholders.
An international outlook and a constructive approach to working within company standards and procedures will help you thrive in this role.
Sobi specializes in developing and delivering therapies for rare diseases. It focuses on hematology, immunology, and specialty care, bringing medicines to patients who have limited treatment options. Their products are designed to treat rare conditions and are typically administered by prescription under medical supervision; the company collaborates with partners to advance research, develop, and commercialize these therapies. Sobi differentiates itself through its strong biotechnological foundation from its Biovitrum heritage and a track record of strategic collaborations with major pharmaceutical players like Sanofi and Apellis, which expand its research capabilities and reach. The company’s goal is to improve the lives of patients with rare diseases worldwide by creating and delivering effective treatments that address unmet medical needs.
Explore more opportunities at Sobi